• Cervical cancer patients report prolonged quality of life (QOL) disruption, and are a vulnerable survivor population.
health-related quality of life (25% and 10%, respectively, N1 SD above the US population mean) compared to adults with no cancer history (10% and 5%, respectively). Cervical cancer survivors, and shortsurvival cancer survivors, report the worst mental health-related quality of life [8] .
Persistent sequelae include pain, bladder and bowel dysfunction [9] [10] [11] [12] , sexual dysfunction [13] [14] [15] [16] , lymphedema, and menopausal symptoms [17] as well as reproductive concerns among women of childbearing age [5, [18] [19] [20] [21] . Adverse psychological consequences are shared with women diagnosed with other gynecologic tumors, and include depression and anxiety [22] , sleep disturbance, and concentration difficulties to a greater magnitude than many other cancer patient populations [23] [24] [25] . Despite challenges inherent in this cancer survivor population, supportive interventions may assist in significantly improving quality of life, with potential to also improve stress-related biomarkers [26] . This could, in turn, improve disease outcomes [27] [28] [29] .
Although QOL has traditionally been examined as an outcome, it has also been considered as a predictor of survival [4, 16, 30] . To that end, QOL and other patient reported outcome (PRO) measures can identify cancer patients most at risk for subsequent health problems. Identification of at-risk survivor populations can guide the allocation of supportive care measures during and after cancer treatment. The purpose of this study is to identify factors associated with compromised quality of life for cervical cancer survivors.
Methods
Cervical cancer patients, identified through the California Cancer Registries (CCR), were recruited and consented to participate in a randomized psychosocial telephone counseling trial from 2008 to 2012. Thirty percent of eligible subjects enrolled in the study. Baseline PRO measures were collected subsequent to informed consent and analyzed for associations with patient characteristics.
Eligibility criteria
Participants were eligible for this study if they had been diagnosed with Stage I, II, III or IVa disease, had completed definitive cancer treatment at least two months earlier and were free of disease, and were diagnosed not more than 30 months prior to enrollment. All patients provided informed consent consistent with federal, state and local requirements prior to enrolling in the study. Baseline questionnaires were completed by patients in English or Spanish prior to randomization to telephone counseling or usual care.
Measures

Quality of life
The FACT-Cx (Functional Assessment of Cancer Therapy-Cervical) is a multidimensional, combined generic and disease-specific QOL questionnaire for cervical cancer patients. Scores range from 0 to 168 with higher scores indicating better QOL. The FACT-G (general) questionnaire (version 4) is a 27-item self-report measure that consists of four subscales (physical well-being, social well-being, emotional wellbeing and functional well-being) [31, 32] , and an additional concerns subscale, which consists of fifteen items reflecting issues specific to cervical cancer. Scales can be analyzed separately, summed to produce a total FACT-Cx QOL score, or combining the Physical, Functional and Additional Concerns to produce the FACT-Trial Outcome Index (FACT-TOI).
Gynecologic problems
The Gynecologic Problems Checklist (GPC) [2, 33, 34] identifies the type and magnitude of gynecologic problems using two subscales: gynecologic problems (e.g., pelvic pain, vaginal dryness; Cronbach's alpha = 0.72) and sexual dysfunction (e.g., pain with intercourse, loss of interest in sexual activities; Cronbach's alpha = 0.90). Subscales are summed to yield a total score ranging from 10 to 50 with higher scores reflecting greater severity.
Emotional distress
The Patient-Reported Outcomes Measurement Information System (PROMIS; www.NIHPROMIS.org) short forms were used to measure depression and anxiety. The PROMIS emotional distress short form consists of 15 items; 8 items on depression and 7 items on anxiety. Each item in the PROMIS SF is scored from 1 to 5 points where, 1 = never, 2 = rarely, 3 = sometimes, 4 = often and 5 = always. A high score on these PROMIS short forms connotes more emotional distress (i.e., more depression or anxiety). Standardized T-scores are calculated with mean = 50 and SD = 10. T-scores are normed to the general population so that a score of 50 represents the mean for the US population; a score of 60 denotes a level of depression or anxiety that is one standard deviation above the general population mean.
The Brief Symptom Inventory (BSI-18), also used in this study, is a measure of psychological distress. Each item is rated on a 5-point Likert scale from 0 (not at all) to 4 (always/extremely). Patients are asked to respond to each item in terms of "how they have been feeling during the past 7 days." The BSI-18 includes subscales measuring depression, anxiety and somatization, as well as an overall total score. Standardized scores are normed to the general population, with a mean of 50 and SD = 10 [2, 35] .
Social support
The MOS Social Support measure is a 19-item, multidimensional, self-administered survey of social support developed for the Medical Outcomes Survey of patients with chronic conditions [36] . Items reflect how often a particular source of support is available and are scored from 1 (none of the time) to 5 (all of the time). The scale has been shown to have good construct validity, high reliability (alpha N 0.91 for all subscales) and to be stable over time.
Coping
The Brief COPE is a 28-item questionnaire adapted from the full COPE [37] and is designed to measure ways in which people respond to stress. Factor structure is similar to the full COPE. Items ask about coping strategies used over the past month and are rated on a 4-point Likert scale ranging from 1 = "I didn't do this at all" to 4 = "I did this a lot". In this study, we created subscales, which distinguish between adaptive (Cronbach's alpha = 0.87) and maladaptive (Cronbach's alpha = 0.68) coping.
Perceived stress
The 10-item Perceived Stress Scale assesses perceptions of stress over the past month [38] . Items reflect how frequently the patient experienced a specific feeling/state, and are rated on a 5-point Likert scale (0 = never to 4 = very often). The PSS has good construct and convergent validity as evidenced by correlations with other measures of stress and self-reported health. Possible scores range from 0 to 40 with higher scores reflecting greater distress [39] .
Medical outcomes sleep scale
The 12-item self-reported sleep measure developed for the Medical Outcomes Study (MOS) provides assessment of various dimensions of sleep including initiation, maintenance, respiratory problems, quantity, perceived adequacy and somnolence [40] . A 9-item sleep problems index ranges from 0 (no problems) to 100 (severe sleep problems). Internal consistency reliability estimates for the MOS sleep scales were ≥ 0.63. The MOS sleep measure has been validated in the US general population and patients with neuropathic pain and found to be responsive to change over time in clinical trials [40] .
Sociodemographic and disease characteristics
Age, ethnicity, marital status, education, and income data were collected by questionnaire at baseline. Comorbidities prior to cancer diagnosis were self-reported by patients using a 29-item checklist. Disease stage was derived from the CCR database from which patients were recruited. Treatment data were provided by patients at baseline, and validated by comparison to the CCR data.
Statistical analyses
Summary scores were calculated for all outcome measures with some imputation for missing values. Only 1.7% of the total number of items was missing and deemed to be missing at random. Missing items were handled according to the administration/scoring procedures in the FACT manual, prorating subscales scores under the constraints that N50% of subscale items and N 80% of all items must be completed in order to create subdomain and total scores (www.facit.org). Among subjects who had completed at least 80% of all items but had some missing data, the average number of missing items ranged from 1.2 to 2.4 items for the various scales reported. Descriptive statistics were computed for all patient characteristics and outcome measures (means and SDs for continuous variables, frequencies and percentages for categorical variables). Associations between patient characteristics and outcome measures were first tested using bivariate t-tests and analysis of variance. Sociodemographic and disease characteristics that were significantly associated with at least one of the outcome measures (p b 0.05) were included in multivariable analyses. Marital status and time from diagnosis to assessment were not significantly associated with any outcome measure and were therefore not included. Income was correlated with education (r = 0.32) and was missing for 15% of subjects, thus was not included in multivariate analyses. Adjusted associations between PRO measures and sociodemographic, tumor and treatment variables were tested using multivariable linear models (SYSTAT version 13.0). Effect sizes for PROs were calculated as the difference between subgroup means divided by the SD for the pooled group. Effects in the range of 0.33 to 0.5 have been considered to be a minimal clinically important difference [41, 42] . Stepwise linear models with backward elimination and p = 0.15 to remove variables were used to identify independent factors associated with QOL. Only 15 patients were treated with radiation alone, thus analyses examined the effects of radiation ± chemotherapy compared to surgery only. Detailed stage information was not available for most patients. Because 73% of women had stage I disease and one-third of these were treated with radiation therapy, stage of disease per se was not informative for multivariate analyses, and instead cancer treatment differences were examined by surgery-only versus radiation ± chemotherapy. Variables entered in the stepwise model included sociodemographics (age, ethnicity and education), treatment, depression, anxiety, somatization, social support, gynecologic problems, coping and sleep disturbance.
Results
Sociodemographic and disease characteristics
Between October 2008 and May 2012, 204 patients were enrolled into the study and completed the baseline assessments, Sociodemographic and disease characteristics are summarized in Table 1 . Forty-one percent were Hispanic and 52% were non-Hispanic White. The mean age at study entry was 43.1 years (range, 22-73) and participants were, on average, 19 months past diagnosis (range, 9-30 months) before enrolling in the study. Most participants (73%) had stage I disease and all had completed treatment prior to participation. Forty-nine percent (n = 100) were treated with surgery only while 51% (n = 104) received radiation with or without chemotherapy. Compared to subjects who declined to participate, those who enrolled were significantly more likely to have early stage disease (73% vs. 61%), be of non-Hispanic white ethnicity (52% vs. 38%), and have a younger age at diagnosis (43 vs. 50 years). However, enrolled subjects included a representative proportion of Hispanics (41% compared to 40% among refusers) and did not differ significantly with respect to treatment.
Quality of life and associations with other PRO measures
Means and standard deviations for all PROs are presented in Table 2 . Figs. 1 and 2 illustrate that PROMIS T-scores for depression and anxiety were N55 (0.5 SD above the mean) in 45% and 47% of patients, respectively, while 26% and 28% of patients had T-scores of N60, reflecting clinically significant emotional distress. Among women in the lowest QOL quartile (FACT-Cx b 110), depression and anxiety T-scores of N60 were reported by 63% and 59%, respectively ( Figs. 1 and 2) . In Table 3 , we report both statistical significance and effect size in terms of number of standard deviations to identify characteristics that contribute to clinically important differences in QOL and other PROs.
Quality of life, PROs and associations with cancer treatment
There were notable cancer treatment-associated differences in QOL and PROs (Table 3) . Patients who received radiation with or without chemotherapy reported significantly worse QOL (FACT-Cx, p = 0.014; FACT-TOI, p = 0.006) after adjusting for other covariates, compared to the surgery-only patients. Effect sizes were N 0.4 SD in magnitude. Patients receiving radiation with or without chemotherapy also reported higher perceived stress (PSS, p = 0.031, effect size = 0.38 SD) depression (ED-Dep TS, p = 0.051, effect size = 0.35 SD) and anxiety (EDAnx TS, p = 0.079, effect size = 0.31 SD). Gynecologic problems were also significantly more frequent in those who received radiation (GPC, p = 0.001, effect size = 0.60 SD) and maladaptive coping was higher (p = 0.013, effect size = 0.44 SD) compared to patients who had surgery only.
Quality of life, PROs and associations with comorbidities
Forty percent of patients reported no major illness prior to their cancer diagnosis, while 32% reported 3 or more comorbid conditions that predated the cancer diagnosis. Among these co-morbid conditions, in greatest frequency, 21% reported back pain, 18% reported depression, 16% reported migraine headaches and 15% reported anxiety. Prior comorbid conditions were associated with significantly lower QOL (p b 0.001 for both FACT-Cx and FACT-TOI), significantly higher perceived stress, depression and anxiety (p b 0.01 for each), and significantly lower social support (p = 0.002). Effect sizes were large, ranging from 0.56 to 0.95. Reported comorbid conditions were not associated with gynecologic problems or coping.
Multivariable prediction of quality of life
Sociodemographic and patient characteristics alone explained only a small proportion of the variance in QOL with R-squared = 0.23. When sociodemographics, patient characteristics and PROs were included in a multivariable linear model to explain overall QOL (Table 4 ); higher levels of depression, somatization, gynecologic problems, sleep disturbance, comorbidities prior to cancer diagnosis, and lower levels of adaptive coping, social support and education were independently associated with lower QOL (p b 0.04 for each). Standard coefficients indicate that gynecologic problems, social support, depression, and somatization (BSI) were most strongly associated with poor QOL while coping, comorbidity, sleep disturbance and education explained smaller amounts of the variance. The adjusted squared multiple correlation was 0.74. Anxiety was not included in the model because of low tolerance and multi-collinearity. Because treatment with radiation with or without chemotherapy is associated with poor outcome for nearly every PRO, treatment was not independently associated with QOL in the multivariate model after inclusion of other PROs. Age, ethnicity and perceived stress were not significantly associated with QOL after adjusting for other variables.
Discussion
The purpose of this study was to identify factors associated with poor quality of life among cervical cancer survivors, in order to identify emotional, physical or social domains that could be prioritized for screening and supportive care. To our knowledge, this is the first study to identify the substantial symptoms of depression and anxiety in this survivor population, which exist long after cancer treatment has concluded. This magnitude of distress clearly influences and disrupts overall quality of life. For example, among women in the lowest quartile for QOL (as measured by the FACT-Cx b 110), 63% reported depression and 59% reported anxiety on the PROMIS measures, with scores that exceeded the clinically meaningful threshold [43] . Notably, these scores represent a tentative threshold for moderate depression, which PROMIS has set on the Depression measure of 60, or 1 SD above the population mean [43, 44] . Our results on emotional distress correspond to a similar population-based study from the Netherlands, which also reported that the cervical cancer survivor population had mental health scores worse than the reference population [6] .
Patients reporting the worst QOL also reported more gynecologic problems, and less social support. The direct and buffering effects of social support among gynecologic cancer survivors has been previously illustrated [45] , and may lend further insight to inform supportive care interventions for this population. Persistent gynecologic problems, however, can be linked to cancer treatment. Not surprisingly, gynecological problems were significantly worse in patients treated with radiation with or without chemotherapy, compared to those treated with surgery only, with a moderate-to-large effect size, which is both statistically and clinically significant. Treatment with radiation with or without chemotherapy also contributed to significantly poorer QOL, higher perceived stress and greater depression, with modest-to-moderate effect sizes. Use of a clinic-based gynecologic problems checklist could potentially serve as a physician-patient communication tool while simultaneously monitoring outcomes. Although it is known that radiated patients generally have poorer QOL, we did not expect that they also suffered more stress and depression. Therefore, one could anticipate that patients receiving radiation therapy could be considered an especially vulnerable subpopulation within a population that is already at greater risk of poor QOL during survivorship.
Furthermore, patients with three or more comorbidities prior to cancer diagnosis also reported significantly worse QOL, higher perceived stress, more depression and anxiety, and lower social support. In identifying subpopulations that are likely to benefit from supportive care interventions, it appears that a brief screening of type and number of premorbid medical problems, including mood disorders, could target those at greatest need for more immediate care and attention, as well as future cancer control studies. Early screening of distress, consistent with NCCN guidelines [46] , QOL and premorbid conditions could assist in patient comfort, and perhaps compliance, during and subsequent to treatment. Although our earlier pilot of a psychosocial telephone counseling intervention did promote quality of life improvement [26] , we did not screen for distress. Therefore, further study of supportive care interventions to improve distress and decrease gynecologic problems in this vulnerable population appear warranted, particularly for women whose cancer treatment extends beyond surgery. Age, ethnicity, treatment, and perceived stress were not significant in the multivariate model (p N 0.3 for each). Anxiety (BSI and ED) was excluded from the model because of low tolerance (b0.4).
